ConductScience.org, home

Trial · NCT02646423

Effect of a Patient-Centered Decision App on TOLAC

NCT02646423, Not applicable, Completed, University of California, San Francisco; results first posted 2021-02-02

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effect of a Patient-Centered Decision App on TOLAC. Trials, record NCT02646423. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02646423

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effect of a Patient-Centered Decision App on TOLAC
NCT number
NCT02646423
Status
Completed
Phases
Not applicable
Enrollment
1,485 participants, actual
Lead sponsor
University of California, San Francisco
Conditions
Pregnancy, Repeat Cesarean Section, Vaginal Births After Cesarean
Interventions
Prior CD Decision App
First posted
2016-01-05
Last updated
2021-02-02
Results first posted
2021-02-02

Source ClinicalTrials.gov

Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of Participants Who Underwent a Trial of Labor After Cesarean (TOLAC) Delivery0-8 weeks after deliveryNumber of participants who underwent a trial of labor after cesarean (TOLAC) delivery, as noted in the medical record.
SecondaryNumber of Participants Who Underwent Vaginal Birth After Cesarean (VBAC)0 to 8 weeks after deliveryNumber of participants who underwent vaginal birth after cesarean (VBAC), as noted in the medical record.
SecondaryKnowledge About TOLAC and ERCDApprox 34-37 weeks gestation8-item knowledge scale, administered during telephone interview. Scores ranged from 0 to 8 with higher scored indicating greater knowledge.
SecondaryDecisional ConflictApprox 34-37 weeks gestation
16-item Decisional Conflict Scale with 5 response categories, administered during telephone interview. Scoring: total scale-0 (no decisional conflict) to 100 (extreme decisional conflict) lower values indicate lower decisional conflict.
SecondaryShared Decision MakingApprox 34-37 weeks gestation
9-item Shared Decision Making Scale, administered during telephone interview. Shared decision-making was measured using the 9-item Shared Decision Making Questionnaire (SDM-Q-9), a psychometrically evaluated tool. The core instrument consists of nine statements, which can be rated on a six-point scale from "completely disagree" (0) to "completely agree" (5). The Shared Decision Score can range from 0 to 100, with higher scores indicating more shared decision-making.
SecondaryDecision Self-EfficacyApprox 34-37 weeks gestation
11-item Decisional Self-Efficacy Scale, administered during telephone interview. The total score is calculated by summing the 11 items, dividing by 11 and multiplying by 25. Scores range from 0 (not confident) to 100 (extremely confident).
SecondaryDecision SatisfactionApprox 34-37 weeks gestation6-item Satisfaction with Decision Scale, administered during telephone interview. Satisfaction With Decision Scale scores range from 0 to 5, with higher scores indicating more satisfaction.
SecondaryMaternal Major MorbidityCollected 0 to 8 weeks after delivery.Defined as any of: uterine rupture, hysterectomy, surgical injury (bowel, bladder/ureter, or other), maternal death, as noted in the medical record for her delivery.
SecondaryMaternal Minor MorbidityCollected 0 to 8 weeks after delivery.Defined as any of: blood transfusion, postpartum febrile morbidity (endometritis, cellulitis, urinary tract infection, or other infection), as noted in the medical record for her delivery.
Secondary3rd or 4th Degree LacerationsCollected 0 to 8 weeks after delivery.3rd or 4th degree lacerations, as noted in the medical record for her delivery.

Outcomes13

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Participants Who Underwent a Trial of Labor After Cesarean (TOLAC) Delivery0-8 weeks after delivery
Prior CD Decision App (PCDDA): no data available for N=8 participants who delivered at outside institution and no chart or outside questionnaire obtained.~Usual Care - No App: no data available for N=3 participants who delivered at outside institution and no chart or outside questionnaire obtained.
ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants Who Underwent Vaginal Birth After Cesarean (VBAC)0 to 8 weeks after delivery
Prior CD Decision App (PCDDA): no data available for N=8 participants who delivered at outside institution and no chart or outside questionnaire obtained.~Usual Care - No App: no data available for N=3 participants who delivered at outside institution and no chart or outside questionnaire obtained.
ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYKnowledge About TOLAC and ERCDApprox 34-37 weeks gestation
Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained, 31 Could not be reached for follow-up, 26 Delivered prior to follow-up interview, 2 Had pregnancy loss ≥22 wk.~Usual Care - No App: 681 Follow-up telephone interviews obtained, 31 Could not be reached for follow-up, 23 Delivered prior to follow-up interview.
score on a scaleMEAN
SECONDARYDecisional ConflictApprox 34-37 weeks gestation
Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained. Responses on the Decisional Conflict Scale missing for 5 participants with PCDAA.~Usual Care-No App: 681 Follow-up interviews obtained. Responses on the Decisional Conflict Scale missing for 6 participants with usual care.
score on a scaleMEAN
SECONDARYShared Decision MakingApprox 34-37 weeks gestation
Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained. Responses on the Shared Decision Making Scale missing for 12 participants with PCDAA.~Usual Care-No App: 681 Follow-up interviews obtained. Responses on the Shared Decision Making Scale missing for 9 participants with usual care.
score on a scaleMEAN
SECONDARYDecision Self-EfficacyApprox 34-37 weeks gestation
Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained. Responses on the Decisional Self-Efficacy Scale missing for 6 participants with PCDAA.~Usual Care-No App: 681 Follow-up interviews obtained. Responses on the Decisional Self-Efficacy Scale missing for 9 participants with PCDAA.
score on a scaleMEAN
SECONDARYDecision SatisfactionApprox 34-37 weeks gestation
Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained. Responses on the Decisional Satisfaction Scale missing for 1 participant with PCDAA.~Usual Care-No App: 681 Follow-up interviews obtained. Responses on the Decisional Satisfaction Scale missing for 2 participants with PCDAA.
score on a scaleMEAN
SECONDARYMaternal Major MorbidityCollected 0 to 8 weeks after delivery.
PCDDA: 15 delivered at outside institution and outcome for maternal major morbidity was not obtained.~Usual Care- No app: 12 delivered at outside institution and outcome for maternal major morbidity was not obtained.
ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYMaternal Minor MorbidityCollected 0 to 8 weeks after delivery.
PCDDA: 15 Delivered at outside institution and maternal minor morbidity outcome not collected during chart review. 1 additional without complete chart review information.~No App: 12 Delivered at outside institution and maternal minor morbidity outcome not collected during chart review. 1 additional without complete chart review information.
ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARY3rd or 4th Degree LacerationsCollected 0 to 8 weeks after delivery.
PCDDA: 15 delivered at outside institution and outcome for 3rd or 4th degree lacerations was not obtained.~Usual Care- No app: 12 delivered at outside institution and outcome for 3rd or 4th degree lacerations was not obtained.
ParticipantsCOUNT_OF_PARTICIPANTS

Results by group30

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants Who Underwent a Trial of Labor After Cesarean (TOLAC) DeliveryPrior CD Decision App (PCDDA)315Participants
Number of Participants Who Underwent a Trial of Labor After Cesarean (TOLAC) DeliveryUsual Care - No App338Participants
Number of Participants Who Underwent Vaginal Birth After Cesarean (VBAC)Prior CD Decision App (PCDDA)231Participants
Number of Participants Who Underwent Vaginal Birth After Cesarean (VBAC)Usual Care - No App233Participants
Knowledge About TOLAC and ERCDPrior CD Decision App (PCDDA)5.0Standard Deviation 1.8score on a scale
Knowledge About TOLAC and ERCDUsual Care - No App5.0Standard Deviation 1.7score on a scale
Decisional ConflictPrior CD Decision App (PCDDA)17.2Standard Deviation 12.9score on a scale
Decisional ConflictUsual Care - No App17.5Standard Deviation 13.9score on a scale
Shared Decision MakingPrior CD Decision App (PCDDA)74.4Standard Deviation 14.9score on a scale
Shared Decision MakingUsual Care - No App74.8Standard Deviation 15.9score on a scale

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDPrior CD Decision App (PCDDA)742
Overall StudySTARTEDUsual Care - No App743
Overall StudyCOMPLETEDPrior CD Decision App (PCDDA)735
Overall StudyCOMPLETEDUsual Care - No App735
Overall StudyNOT COMPLETEDPrior CD Decision App (PCDDA)7
Overall StudyNOT COMPLETEDUsual Care - No App8

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityPrior CD Decision App (PCDDA)0727
Total, all-cause mortalityUsual Care - No App0732
Total, other adverse eventsPrior CD Decision App (PCDDA)0727
Total, other adverse eventsUsual Care - No App0732
Total, serious adverse eventsPrior CD Decision App (PCDDA)0727
Total, serious adverse eventsUsual Care - No App0732

Papers15

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
7078857BACKGROUNDPubMed
7898294BACKGROUNDPubMed
8717600BACKGROUNDPubMed
10815084BACKGROUNDPubMed
15598960BACKGROUNDPubMed
16260206BACKGROUNDPubMed
18255248BACKGROUNDPubMed
19879711BACKGROUNDPubMed
20629481BACKGROUNDPubMed
20654776BACKGROUNDPubMed

1 to 10 of 15

See all 15 papers

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
R01HD078748Effect of a patient-centered decision app on TOLAC: An RCTKUPPERMANN, MIRIAMUNIVERSITY OF CALIFORNIA, SAN FRANCISCOEUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT2014 to 2018

Trial comparisons9

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Prior CD Decision App (PCDDA) vs Usual Care - No App: 3rd or 4th Degree LacerationsTrial comparisons
Prior CD Decision App (PCDDA) vs Usual Care - No App: Maternal Major MorbidityTrial comparisons
Prior CD Decision App (PCDDA) vs Usual Care - No App: Number of Participants Who Underwent a Trial of Labor After Cesarean (TOLAC) DeliveryTrial comparisons
Prior CD Decision App (PCDDA) vs Usual Care - No App: Number of Participants Who Underwent Vaginal Birth After Cesarean (VBAC)Trial comparisons
Prior CD Decision App (PCDDA) vs Usual Care - No App: deaths from any causeTrial comparisons
Prior CD Decision App (PCDDA) vs Usual Care - No App: Neonatal Respiratory MorbidityTrial comparisons
Prior CD Decision App (PCDDA) vs Usual Care - No App: Maternal Minor MorbidityTrial comparisons
Prior CD Decision App (PCDDA) vs Usual Care - No App: Neonatal Intensive Care Unit (NICU) AdmissionTrial comparisons
Prior CD Decision App (PCDDA) vs Usual Care - No App: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02646423

GET https://conductscience.org/api/trials/v1/NCT02646423/results?page=2